Tirzepatide, marketed as Mounjaro and Zepbound, is a dual GLP-1 receptor agonist used to treat type 2 diabetes and obesity
CBS Firstly, homocysteine is converted to an intermediate metabolite called cystathionine using the CBS enzyme (cystathionine beta synthase)
By injecting it into the fatty tissue, Semaglutide is gradually absorbed into the bloodstream, ensuring steady and consistent action over time
The FDA also recently approved daily oral pills of semaglutide for weight loss
Potential benefit - A patient whose biomarkers suggest rapid metabolism of GLP-1 drugs might be offered a longer-acting formulation, while someone with strong GIP responsiveness could start on a dual-agonist right away, avoiding months of trial-and-error
"Just got a random hive on my stomach after taking my 4th .5 injection very worried its an allergic reaction." - u/topsy-turvy20s Some reactions fade within a few days